Detalhe da pesquisa
1.
Coadministration of dabigatran etexilate and atorvastatin: assessment of potential impact on pharmacokinetics and pharmacodynamics.
Am J Cardiovasc Drugs
; 9(1): 59-68, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19178132
2.
Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects.
Clin Pharmacokinet
; 47(1): 47-59, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18076218
3.
Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment.
J Clin Pharmacol
; 48(12): 1411-9, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18827075
4.
Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement.
J Clin Pharmacol
; 45(5): 555-63, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15831779
5.
Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, with coadministration of digoxin.
J Clin Pharmacol
; 52(2): 243-50, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21868715
6.
Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study.
Clin Pharmacokinet
; 49(4): 259-68, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20214409
7.
The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects.
Br J Clin Pharmacol
; 64(3): 292-303, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17506785